Home
About
Senior Management
Board of Directors
Scientific Advisory Board
Products
Imatinib
Levosimendan
Education Center
Featured Articles
Education Categories
Viewpoints
Investors/Media
Events & Presentations
Press Releases
Executive Team
Corporate Governance
Analyst Coverage
SEC Filings
Email Alerts
Contact
Investor Relations
Investor Presentation
Overview
Events & Presentations
Press Releases
Executive Team
Corporate Governance
Analyst Coverage
SEC Filings
Email Alerts
Overview
Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies.
Investor Alerts
Receive updates straight to your inbox.
Sign Up Today
Latest News
View All Press Releases
Stock Quote
NASDAQ: TENX
View Stock Chart
IR cONTACT
Argot Partners
tenax@argotpartners.com
© Copyright 2025 Tenax Therapeutics. All Rights Reserved.
Site created by
Issuer Direct
Privacy Policy
Terms of Service
